Detalles de la búsqueda
1.
A genome-wide association meta-analysis on lipoprotein (a) concentrations adjusted for apolipoprotein (a) isoforms.
J Lipid Res
; 58(9): 1834-1844, 2017 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-28512139
2.
Effect of BI 1358894 on Cholecystokinin-Tetrapeptide (CCK-4)-Induced Anxiety, Panic Symptoms, and Stress Biomarkers: A Phase I Randomized Trial in Healthy Males.
CNS Drugs
; 37(12): 1099-1109, 2023 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-38019356
3.
Quantitative electroencephalography parameters as neurophysiological biomarkers of schizophrenia-related deficits: A Phase II substudy of patients treated with iclepertin (BI 425809).
Transl Psychiatry
; 12(1): 329, 2022 08 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-35953474
4.
A Drug-Drug Interaction Study to Investigate the Effect of Nintedanib on the Pharmacokinetics of Microgynon (Ethinylestradiol and Levonorgestrel) in Female Patients with Systemic Sclerosis-Associated Interstitial Lung Disease.
Eur J Drug Metab Pharmacokinet
; 47(1): 81-89, 2022 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-34664183
5.
The Absolute Bioavailability, Absorption, Distribution, Metabolism, and Excretion of BI 425809 Administered as an Oral Dose or an Oral Dose with an Intravenous Microtracer Dose of [14C]-BI 425809 in Healthy Males.
Clin Drug Investig
; 42(1): 87-99, 2022 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-34936055
6.
The effects of transient receptor potential cation channel inhibition by BI 1358894 on cortico-limbic brain reactivity to negative emotional stimuli in major depressive disorder.
Eur Neuropsychopharmacol
; 65: 44-51, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-36343427
7.
Cis-epistasis at the LPA locus and risk of cardiovascular diseases.
Cardiovasc Res
; 118(4): 1088-1102, 2022 03 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-33878186
8.
Evaluating the Causal Relation of ApoA-IV with Disease-Related Traits - A Bidirectional Two-sample Mendelian Randomization Study.
Sci Rep
; 7(1): 8734, 2017 08 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-28821713
9.
Correction to: The Absolute Bioavailability, Absorption, Distribution, Metabolism, and Excretion of BI 425809 Administered as an Oral Dose or an Oral Dose with an Intravenous Microtracer Dose of [14C]BI 425809 in Healthy Males.
Clin Drug Investig
; 42(4): 375, 2022 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-35286627
Resultados
1 -
9
de 9
1
Próxima >
>>